Mannkind (MNKD) Revenue Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 15.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.08% |
| Dec 31, 2025 | 45.82% |
| Sep 30, 2025 | 17.20% |
| Jun 30, 2025 | 5.72% |
| Mar 31, 2025 | 18.25% |
| Dec 31, 2024 | 31.30% |
| Sep 30, 2024 | 36.73% |
| Jun 30, 2024 | 48.91% |
| Mar 31, 2024 | 63.10% |
| Dec 31, 2023 | 62.16% |
| Sep 30, 2023 | 56.14% |
| Jun 30, 2023 | 16,103.67% |
| Mar 31, 2023 | 238.78% |
| Dec 31, 2022 | 188.13% |
| Sep 30, 2022 | 47.79% |
| Jun 30, 2022 | -98.71% |
| Mar 31, 2022 | -31.22% |
| Dec 31, 2021 | -32.14% |
| Sep 30, 2021 | 44.68% |
| Jun 30, 2021 | 11,540.00% |
| Mar 31, 2021 | 7.40% |
| Dec 31, 2020 | 15.32% |
| Sep 30, 2020 | 2,093.14% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | -6.95% |
| Dec 31, 2019 | -0.24% |
| Sep 30, 2019 | -84.34% |
| Jun 30, 2019 | -94.86% |
| Mar 31, 2019 | 403.55% |
| Dec 31, 2018 | 253.89% |
| Sep 30, 2018 | 118.75% |
| Jun 30, 2018 | 79.98% |
| Mar 31, 2018 | 15.15% |
| Dec 31, 2017 | -63.48% |
| Sep 30, 2017 | -98.74% |